000 01394 a2200373 4500
005 20250517181823.0
264 0 _c20181012
008 201810s 0 0 eng d
022 _a1528-0020
024 7 _a10.1182/blood-2017-07-791608
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDossa, Robson G
245 0 0 _aDevelopment of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.
_h[electronic resource]
260 _bBlood
_c01 2018
300 _a108-120 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCells, Cultured
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLeukemia
_ximmunology
650 0 4 _aMinor Histocompatibility Antigens
_xmetabolism
650 0 4 _aOligopeptides
_xmetabolism
650 0 4 _aReceptors, Antigen, T-Cell
_xmetabolism
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aCunningham, Tanya
700 1 _aSommermeyer, Daniel
700 1 _aMedina-Rodriguez, Indira
700 1 _aBiernacki, Melinda A
700 1 _aFoster, Kimberly
700 1 _aBleakley, Marie
773 0 _tBlood
_gvol. 131
_gno. 1
_gp. 108-120
856 4 0 _uhttps://doi.org/10.1182/blood-2017-07-791608
_zAvailable from publisher's website
999 _c27703587
_d27703587